Meditation programs for psychological stress and well-being: a systematic review and meta-analysis - PubMed (original) (raw)

Review

. 2014 Mar;174(3):357-68.

doi: 10.1001/jamainternmed.2013.13018.

Sonal Singh 1, Erica M S Sibinga 2, Neda F Gould 3, Anastasia Rowland-Seymour 1, Ritu Sharma 4, Zackary Berger 1, Dana Sleicher 3, David D Maron 4, Hasan M Shihab 4, Padmini D Ranasinghe 1, Shauna Linn 4, Shonali Saha 2, Eric B Bass 5, Jennifer A Haythornthwaite 3

Affiliations

Review

Meditation programs for psychological stress and well-being: a systematic review and meta-analysis

Madhav Goyal et al. JAMA Intern Med. 2014 Mar.

Abstract

Importance: Many people meditate to reduce psychological stress and stress-related health problems. To counsel people appropriately, clinicians need to know what the evidence says about the health benefits of meditation.

Objective: To determine the efficacy of meditation programs in improving stress-related outcomes (anxiety, depression, stress/distress, positive mood, mental health-related quality of life, attention, substance use, eating habits, sleep, pain, and weight) in diverse adult clinical populations.

Evidence review: We identified randomized clinical trials with active controls for placebo effects through November 2012 from MEDLINE, PsycINFO, EMBASE, PsycArticles, Scopus, CINAHL, AMED, the Cochrane Library, and hand searches. Two independent reviewers screened citations and extracted data. We graded the strength of evidence using 4 domains (risk of bias, precision, directness, and consistency) and determined the magnitude and direction of effect by calculating the relative difference between groups in change from baseline. When possible, we conducted meta-analyses using standardized mean differences to obtain aggregate estimates of effect size with 95% confidence intervals.

Findings: After reviewing 18 753 citations, we included 47 trials with 3515 participants. Mindfulness meditation programs had moderate evidence of improved anxiety (effect size, 0.38 [95% CI, 0.12-0.64] at 8 weeks and 0.22 [0.02-0.43] at 3-6 months), depression (0.30 [0.00-0.59] at 8 weeks and 0.23 [0.05-0.42] at 3-6 months), and pain (0.33 [0.03- 0.62]) and low evidence of improved stress/distress and mental health-related quality of life. We found low evidence of no effect or insufficient evidence of any effect of meditation programs on positive mood, attention, substance use, eating habits, sleep, and weight. We found no evidence that meditation programs were better than any active treatment (ie, drugs, exercise, and other behavioral therapies).

Conclusions and relevance: Clinicians should be aware that meditation programs can result in small to moderate reductions of multiple negative dimensions of psychological stress. Thus, clinicians should be prepared to talk with their patients about the role that a meditation program could have in addressing psychological stress. Stronger study designs are needed to determine the effects of meditation programs in improving the positive dimensions of mental health and stress-related behavior.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Figure 1A: Summary across measurement domains of comparisons of meditation programs with non-specific active controls Figure 1B. Summary across measurement domains of comparisons of meditation programs with specific active controls

  1. CSM = Clinically Standardized Meditation, a mantra meditation program; TM=Transcendental Meditation, a mantra meditation program
  2. CHF = Congestive Heart Failure; CAD = Coronary Artery Disease
  3. PO = Number of trials in which this was a primary outcome for the trial; PA = Primary Analysis; MA = Meta-analysis; N = sample size
  4. Direction based on relative difference in change analysis:
    ↑ indicates that the meditation group improved relative to the control group (with a relative difference generally greater than or equal to 5 percent across trials).
    ↓ indicates the meditation group worsened relative to the control group (with a relative difference generally greater than or equal to 5 percent across trials).
    Ø indicates a null effect (with a relative difference generally less than 5 percent across trials).
    ↑↓ indicates inconsistent findings (some trials reported improvement with meditation [relative to control] while others showed no improvement or improvement in the control group [relative to meditation]).
  5. Magnitude based on relative difference in the change score: This is a relative percent difference, using the baseline mean in the meditation group as the denominator. For example, if the meditation group improves from a 10 to 19 on a mental health scale and the control group improves from 11 to 16 on the same scale, the relative difference between groups in the change score is: (((19-10)-(16-11))/10)x100=40%. The interpretation is that there is a 40% relative improvement on the mental health scale in the meditation group compared with the control group. Improvement in all scales is indicated in the positive direction. A positive relative percent difference means that the score improved more in the intervention group than in the control group

Meta-analysis figure on far right shows Cohen’s d with the 95% CI * Summary effect size not shown due to concern for publication bias for this outcome **Negative affect combines the outcomes of anxiety, depression, stress/distress, and is thus duplicative of those outcomes *** We did not perform meta-analysis on this outcome since it would duplicate the anxiety meta-analysis for mantra. Anxiety and depression are indirect measures of negative affect, and therefore resulted in a lower strength of evidence than for the outcome of mantra on anxiety.

Figure 1

Figure 1

Figure 1A: Summary across measurement domains of comparisons of meditation programs with non-specific active controls Figure 1B. Summary across measurement domains of comparisons of meditation programs with specific active controls

  1. CSM = Clinically Standardized Meditation, a mantra meditation program; TM=Transcendental Meditation, a mantra meditation program
  2. CHF = Congestive Heart Failure; CAD = Coronary Artery Disease
  3. PO = Number of trials in which this was a primary outcome for the trial; PA = Primary Analysis; MA = Meta-analysis; N = sample size
  4. Direction based on relative difference in change analysis:
    ↑ indicates that the meditation group improved relative to the control group (with a relative difference generally greater than or equal to 5 percent across trials).
    ↓ indicates the meditation group worsened relative to the control group (with a relative difference generally greater than or equal to 5 percent across trials).
    Ø indicates a null effect (with a relative difference generally less than 5 percent across trials).
    ↑↓ indicates inconsistent findings (some trials reported improvement with meditation [relative to control] while others showed no improvement or improvement in the control group [relative to meditation]).
  5. Magnitude based on relative difference in the change score: This is a relative percent difference, using the baseline mean in the meditation group as the denominator. For example, if the meditation group improves from a 10 to 19 on a mental health scale and the control group improves from 11 to 16 on the same scale, the relative difference between groups in the change score is: (((19-10)-(16-11))/10)x100=40%. The interpretation is that there is a 40% relative improvement on the mental health scale in the meditation group compared with the control group. Improvement in all scales is indicated in the positive direction. A positive relative percent difference means that the score improved more in the intervention group than in the control group

Meta-analysis figure on far right shows Cohen’s d with the 95% CI * Summary effect size not shown due to concern for publication bias for this outcome **Negative affect combines the outcomes of anxiety, depression, stress/distress, and is thus duplicative of those outcomes *** We did not perform meta-analysis on this outcome since it would duplicate the anxiety meta-analysis for mantra. Anxiety and depression are indirect measures of negative affect, and therefore resulted in a lower strength of evidence than for the outcome of mantra on anxiety.

Figure 2

Figure 2. Summary of the literature search

* Total exceeds the number in the exclusion box because reviewers were allowed to mark more than 1 reason for exclusion

Comment in

Similar articles

Cited by

References

    1. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;(12):1–23. - PubMed
    1. Goyal M, Haythornthwaite J, Levine D, et al. Intensive meditation for refractory pain and symptoms. J Altern Complement Med. 2010;16(6):627–31. - PMC - PubMed
    1. Rapgay L, Bystrisky A. Classical mindfulness: an introduction to its theory and practice for clinical application. Ann N Y Acad Sci. 2009;1172:148–62. - PubMed
    1. Travis F, Shear J. Focused attention, open monitoring and automatic self-transcending: Categories to organize meditations from Vedic, Buddhist and Chinese traditions. Conscious Cogn. 2010 Dec;19(4):1110–8. - PubMed
    1. Chiesa A, Malinowski P. Mindfulness-based approaches: are they all the same? J Clin Psychol. 2011;67 (4):404–24. - PubMed

Publication types

MeSH terms

LinkOut - more resources